NCCN task force report: Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy

Gary R. Hudes, Michael A. Carducci, Toni K. Choueiri, Peg Esper, Eric Jonasch, Rashmi Kumar, Kim A. Margolin, M. Dror Michaelson, Robert J. Motzer, Roberto Pili, Susan Roethke, Sandy Srinivas

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The outcome of patients with metastatic renal cell carcinoma has been substantially improved with administration of the currently available molecularly targeted therapies. However, proper selection of therapy and management of toxicities remain challenging. NCCN convened a multidisciplinary task force panel to address the clinical issues associated with these therapies in attempt to help practicing oncologists optimize patient outcomes. This report summarizes the background data presented at the task force meeting and the ensuing discussion.

Original languageEnglish (US)
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume9
Issue numberSUPPL. 1
StatePublished - 2011
Externally publishedYes

Fingerprint

Molecular Targeted Therapy
Advisory Committees
Renal Cell Carcinoma
Therapeutics

Keywords

  • Molecular targeted therapy
  • mTOR
  • NCCN
  • Patient outcomes
  • Renal cell carcinoma
  • TKI
  • VEGF

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)

Cite this

Hudes, G. R., Carducci, M. A., Choueiri, T. K., Esper, P., Jonasch, E., Kumar, R., ... Srinivas, S. (2011). NCCN task force report: Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy. JNCCN Journal of the National Comprehensive Cancer Network, 9(SUPPL. 1).

NCCN task force report : Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy. / Hudes, Gary R.; Carducci, Michael A.; Choueiri, Toni K.; Esper, Peg; Jonasch, Eric; Kumar, Rashmi; Margolin, Kim A.; Michaelson, M. Dror; Motzer, Robert J.; Pili, Roberto; Roethke, Susan; Srinivas, Sandy.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 9, No. SUPPL. 1, 2011.

Research output: Contribution to journalArticle

Hudes, GR, Carducci, MA, Choueiri, TK, Esper, P, Jonasch, E, Kumar, R, Margolin, KA, Michaelson, MD, Motzer, RJ, Pili, R, Roethke, S & Srinivas, S 2011, 'NCCN task force report: Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy', JNCCN Journal of the National Comprehensive Cancer Network, vol. 9, no. SUPPL. 1.
Hudes, Gary R. ; Carducci, Michael A. ; Choueiri, Toni K. ; Esper, Peg ; Jonasch, Eric ; Kumar, Rashmi ; Margolin, Kim A. ; Michaelson, M. Dror ; Motzer, Robert J. ; Pili, Roberto ; Roethke, Susan ; Srinivas, Sandy. / NCCN task force report : Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy. In: JNCCN Journal of the National Comprehensive Cancer Network. 2011 ; Vol. 9, No. SUPPL. 1.
@article{1b47417576e74bb3a436a23499c9a29d,
title = "NCCN task force report: Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy",
abstract = "The outcome of patients with metastatic renal cell carcinoma has been substantially improved with administration of the currently available molecularly targeted therapies. However, proper selection of therapy and management of toxicities remain challenging. NCCN convened a multidisciplinary task force panel to address the clinical issues associated with these therapies in attempt to help practicing oncologists optimize patient outcomes. This report summarizes the background data presented at the task force meeting and the ensuing discussion.",
keywords = "Molecular targeted therapy, mTOR, NCCN, Patient outcomes, Renal cell carcinoma, TKI, VEGF",
author = "Hudes, {Gary R.} and Carducci, {Michael A.} and Choueiri, {Toni K.} and Peg Esper and Eric Jonasch and Rashmi Kumar and Margolin, {Kim A.} and Michaelson, {M. Dror} and Motzer, {Robert J.} and Roberto Pili and Susan Roethke and Sandy Srinivas",
year = "2011",
language = "English (US)",
volume = "9",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "SUPPL. 1",

}

TY - JOUR

T1 - NCCN task force report

T2 - Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy

AU - Hudes, Gary R.

AU - Carducci, Michael A.

AU - Choueiri, Toni K.

AU - Esper, Peg

AU - Jonasch, Eric

AU - Kumar, Rashmi

AU - Margolin, Kim A.

AU - Michaelson, M. Dror

AU - Motzer, Robert J.

AU - Pili, Roberto

AU - Roethke, Susan

AU - Srinivas, Sandy

PY - 2011

Y1 - 2011

N2 - The outcome of patients with metastatic renal cell carcinoma has been substantially improved with administration of the currently available molecularly targeted therapies. However, proper selection of therapy and management of toxicities remain challenging. NCCN convened a multidisciplinary task force panel to address the clinical issues associated with these therapies in attempt to help practicing oncologists optimize patient outcomes. This report summarizes the background data presented at the task force meeting and the ensuing discussion.

AB - The outcome of patients with metastatic renal cell carcinoma has been substantially improved with administration of the currently available molecularly targeted therapies. However, proper selection of therapy and management of toxicities remain challenging. NCCN convened a multidisciplinary task force panel to address the clinical issues associated with these therapies in attempt to help practicing oncologists optimize patient outcomes. This report summarizes the background data presented at the task force meeting and the ensuing discussion.

KW - Molecular targeted therapy

KW - mTOR

KW - NCCN

KW - Patient outcomes

KW - Renal cell carcinoma

KW - TKI

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=79952784860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952784860&partnerID=8YFLogxK

M3 - Article

C2 - 21335444

AN - SCOPUS:79952784860

VL - 9

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - SUPPL. 1

ER -